Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial
Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.

Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page
- CheckyesterdayChange DetectedUpdates include corrected spelling/formatting for two listed locations and a revised citation entry for a journal article. The page’s displayed site revision version is also updated.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded two 2026 JAMA Cardiol. publications related to the FINEARTS-HF trial: EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial, and Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure.SummaryDifference0.0%

- Check24 days agoChange DetectedA new JAMA Cardiol. 2025 publication is added to the Publications section, and the Erratum for that article is removed.SummaryDifference0.0%

- Check31 days agoChange DetectedThe Napoli entry is updated to Naples, Campania, Italy (80131), and a Nat Med 2024 publication on FINE-HEART with the full author list is added; the study record revision is updated to v3.5.0.SummaryDifference0.0%

- Check39 days agoChange DetectedNew publication citation added to Publications, listing authors for a 2026 Eur J Heart Fail article on finerenone and quality of life in heart failure (online ahead of print).SummaryDifference0.0%

- Check46 days agoChange DetectedAdded two 2026 publications with author lists and DOIs to Publications, removed one earlier citation, and updated the page revision to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.